Clinical trial
Efficacy, Safety and Quality of Life Outcome of Fentanyl Transdermal Patch (Durogesic-D-Trans) Among Filipino Patients With Osteoarthritis and Chronic Low Back Pain
NCT01795898 is registered in ClinicalTrials.gov with Janssen Pharmaceutica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy, Safety and Quality of Life Outcome of Fentanyl Transdermal Patch (Durogesic-D-Trans) Among Filipino Patients With Osteoarthritis and Chronic Low Back Pain
- Lead sponsor
- Janssen Pharmaceutica
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- September 30, 2009
- Enrollment
- 237 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.